<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[vaccine Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/vaccine.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to vaccine]]></description>
	<s:counts start="0" returned="20" found="1510" />
	<language>en-us</language>
	<item>
		<title><![CDATA[The 10 Weirdest Drug Stories of the Month]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005620/the-10-weirdest-drug-stories-of-the-month-15/]]></link>
		<description><![CDATA[A vaccine for smoking! Power hungry Eli Lilly execs! Flu shots from caterpillars! It all happened in November 2009.    	Biogen CEO pay = $148 million for 6 years  Letter to the SEC: "CEO, James Mullen, has sold more than $85 million of stock, which we estimate...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 02 Dec 2009 16:46:27 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/gender+and+diversity.html"><![CDATA[Gender And Diversity]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="tickers">LLY</category>
	</item>
	<item>
		<title><![CDATA[U.S. Approves Glaxo H1N1 Vaccine]]></title>
		<link><![CDATA[http://www.bnet.com/2407-14055_23-363709.html]]></link>
		<description><![CDATA[NEW YORK (<a href="http://resources.bnet.com/index.php?source=ReutersUK">Reuters UK</a>) - GlaxoSmithKline Plc GSK has won U.S. marketing approval to sell an unadjuvanted H1N1 swine vaccine, allowing it to ship relatively modest amounts of scarce vaccine to the United States next month.The company said on Tuesday the Food and Drug Administration had approved a modified version...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Tue, 10 Nov 2009 22:45:39 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/h1n1+flu.html"><![CDATA[H1N1 Flu]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/glaxo.html"><![CDATA[Glaxo]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/noven+pharmaceuticals+inc..html"><![CDATA[Noven Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/oukbs.html"><![CDATA[Oukbs]]></category>
		<category domain="http://resources.bnet.com/topic/us.html"><![CDATA[US]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NOVN</category>
		<category domain="tickers">GSK,NOVN</category>
	</item>
	<item>
		<title><![CDATA[Glaxo Wins U.S. Approval For Swine Flu Vaccine]]></title>
		<link><![CDATA[http://www.bnet.com/2407-14055_23-363672.html]]></link>
		<description><![CDATA[NEW YORK (<a href="http://resources.bnet.com/index.php?source=ReutersUK">Reuters UK</a>) - GlaxoSmithKline Plc GSK has won U.S. marketing approval to sell an unadjuvanted H1N1 swine vaccine, allowing it to ship relatively modest amounts of scarce vaccine to the United States next month.The British company said on Tuesday the Food and Drug Administration had approved a modified...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Tue, 10 Nov 2009 18:31:02 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/h1n1+flu.html"><![CDATA[H1N1 Flu]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/glaxo.html"><![CDATA[Glaxo]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/noven+pharmaceuticals+inc..html"><![CDATA[Noven Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/oukbs.html"><![CDATA[Oukbs]]></category>
		<category domain="http://resources.bnet.com/topic/us.html"><![CDATA[US]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NOVN</category>
		<category domain="tickers">GSK,NOVN</category>
	</item>
	<item>
		<title><![CDATA[The 10 Weirdest Drug Stories of the Month]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005078/the-10-weirdest-drug-stories-of-the-month-14/]]></link>
		<description><![CDATA[Spiders make Viagra! A vaccine for cocaine! Canola genes unlocked! It all happened in October ...    	Contraceptive pills change mating choices of women who use them  "One prediction is that offspring of pill users are more homozygous than expected, possibly related to impaired immune function and...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 02 Nov 2009 10:29:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/researcher.html"><![CDATA[Researcher]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/bonkers+michigan+law.html"><![CDATA[Bonkers Michigan Law]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Swine flu vaccine and strong pipeline give Novartis a shot in the arm]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2F24e49fc8-bf6c-11de-a696-00144feab49a.html&siteid=23&tag=financialtimes]]></link>
		<description><![CDATA[ Novartis yesterday said it expected to sell about $600m worth of its new H1N1 pandemic swine flu vaccine in the fourth quarter, significantly more than the Swiss pharmaceuticals group had earlier forecast.The increase came on top of guidance that the group expected to sell more of its core pharmaceuticals...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 22 Oct 2009 19:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/h1n1+flu.html"><![CDATA[H1N1 Flu]]></category>
		<category domain="http://resources.bnet.com/topic/rejuvenation+effort.html"><![CDATA[Rejuvenation Effort]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/company+news.html"><![CDATA[Company News]]></category>
		<category domain="http://resources.bnet.com/topic/facilities+%2526+equipment.html"><![CDATA[Facilities & Equipment]]></category>
		<category domain="http://resources.bnet.com/topic/general+news.html"><![CDATA[General News]]></category>
		<category domain="http://resources.bnet.com/topic/health+%2526+healthcare.html"><![CDATA[Health & Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/financial+times.html"><![CDATA[Financial Times]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[GSK faces Merck in vaccine price war]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2F0eae7d2a-bcdb-11de-a7ec-00144feab49a.html&siteid=23&tag=financialtimes]]></link>
		<description><![CDATA[ GlaxoSmithKline plans to undercut its rival Merck in a battle for sales following US regulatory approval for its cervical cancer vaccine Cervarix.The UK-based pharmaceutical group said it would charge less than Gardasil, Merck's vaccine, which generates more than $1bn ( by Financial Times]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Mon, 19 Oct 2009 11:56:45 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/company+news.html"><![CDATA[Company News]]></category>
		<category domain="http://resources.bnet.com/topic/general+news.html"><![CDATA[General News]]></category>
		<category domain="http://resources.bnet.com/topic/health+%2526+healthcare.html"><![CDATA[Health & Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/regulation+of+business.html"><![CDATA[Regulation of Business]]></category>
		<category domain="http://resources.bnet.com/topic/financial+times.html"><![CDATA[Financial Times]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Flu vaccine price war hits high street]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2F8e729cda-a70f-11de-bd14-00144feabdc0.html&siteid=23&tag=financialtimes]]></link>
		<description><![CDATA[ Asda, the supermarket chain, has launched a price war for the seasonal flu vaccine with plans to offer injections at £8 each, undercutting high street rivals and the price it offered in its own stores last year.The company portrayed the move as a way to ease pressure on "struggling...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Mon, 21 Sep 2009 19:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/h1n1+flu.html"><![CDATA[H1N1 Flu]]></category>
		<category domain="http://resources.bnet.com/topic/flu+vaccine.html"><![CDATA[Flu Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/company+news.html"><![CDATA[Company News]]></category>
		<category domain="http://resources.bnet.com/topic/competition.html"><![CDATA[Competition]]></category>
		<category domain="http://resources.bnet.com/topic/general+news.html"><![CDATA[General News]]></category>
		<category domain="http://resources.bnet.com/topic/health+%2526+healthcare.html"><![CDATA[Health & Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/new+products+%2526+services.html"><![CDATA[New Products & Services]]></category>
		<category domain="http://resources.bnet.com/topic/prices.html"><![CDATA[Prices]]></category>
		<category domain="http://resources.bnet.com/topic/financial+times.html"><![CDATA[Financial Times]]></category>
	</item>
	<item>
		<title><![CDATA[Merck and Wellcome Trust in vaccine alliance]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2Fddba6ad8-a3af-11de-9fed-00144feabdc0.html&siteid=23&tag=financialtimes]]></link>
		<description><![CDATA[ Merck on Thursday announced a ground-breaking £90m ($148.6m) partnership with the Wellcome Trust to develop vaccines for the developing world.The venture will combine the ideas of academic scientists, with the technical experience of researchers from pharmaceutical companies in an effort to develop affordable and effective vaccines. The MSD Wellcome...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 17 Sep 2009 12:02:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/alliance.html"><![CDATA[Alliance]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/company+news.html"><![CDATA[Company News]]></category>
		<category domain="http://resources.bnet.com/topic/financial+times.html"><![CDATA[Financial Times]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Sinovac Biotech Limited Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-332793.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you. Operator Instructions. Thank you. Our first question today is coming from [Dan Jaffrey], a Private Investor. Please state your question, sir. Dan Jaffrey &#8211; Private Investor Yes. I have a few questions, one is do you have any kind of even rough timetable about what...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Wed, 19 Aug 2009 06:17:28 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/sinovac+biotech+ltd..html"><![CDATA[Sinovac Biotech Ltd.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SVA</category>
		<category domain="tickers">SVA</category>
	</item>
	<item>
		<title><![CDATA[Vical Incorporated Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-329660.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you, Mr. Samant. Operator instructions. Please standby for your first question. Our first question comes from Stephen Willey with Thomas Weisel Partners. Stephen Willey &#8211; Thomas Weisel Partners Yes, thanks for taking the question. Vijay Samant Hi, Stephen. Stephen Willey &#8211; Thomas Weisel Partners Hi, Vijay....]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Fri, 07 Aug 2009 05:58:20 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/h1n1+flu.html"><![CDATA[H1N1 Flu]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/vical+inc..html"><![CDATA[Vical Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VICL</category>
		<category domain="tickers">VICL</category>
	</item>
	<item>
		<title><![CDATA[Wyeth Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-324033.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Thank you. Operator Instructions Your first question comes from Tim Anderson - Sanford Bernstein. Tim Anderson - Sanford Bernstein I have a single question for you, I guess, which is when we're going to learn the results of your go/no go decision for Phase III...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Thu, 23 Jul 2009 11:24:21 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/decision.html"><![CDATA[Decision]]></category>
		<category domain="http://resources.bnet.com/topic/sanford+c.+bernstein+%2526+co..html"><![CDATA[Sanford C. Bernstein & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
		<category domain="tickers">WYE</category>
	</item>
	<item>
		<title><![CDATA[Merck KGaA on Cancer Vaccines: We're Not Crazy, Just Convinced]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10003090/merck-kgaa-on-cancer-vaccines-were-not-crazy-just-convinced/]]></link>
		<description><![CDATA[Merck KGaA claims they arenâ€™t crazy for initiating a Phase III breast cancer trial with the therapeutic cancer vaccine Stimuvax -- theyâ€™re just completely convinced the darn thing is going to work. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 13 Jul 2009 22:24:02 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[Breast Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Sanofi Eats Merck's Vaccine Business for Lunch; Hopes Pinned on "Gardasil for Boys"]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10002891/sanofi-eats-mercks-vaccine-business-for-lunch-hopes-pinned-on-gardasil-for-boys/]]></link>
		<description><![CDATA[Merck should have been cheered by the news that the CDC plans to reinstate booster shots of meningitis vaccine for kids because the vaccine supply has come back online. The company, after all, has a large vaccine division. But it is just salt in Merck's wounds. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 26 Jun 2009 11:44:30 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi.html"><![CDATA[Sanofi]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Is Merck KGaA Crazy? Or Just Crazy About Cancer Vaccines?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10002833/is-merck-kgaa-crazy-or-just-crazy-about-cancer-vaccines/]]></link>
		<description><![CDATA[Merck KGaAâ€™s decision to start a Phase III trial in breast cancer with the therapeutic cancer vaccine Stimuvax -- which failed a Phase II lung cancer trial and is untested in breast cancer -- begs the question: Has the German big pharma gone nuts? by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 23 Jun 2009 21:44:38 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[Breast Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/merck+kgaa.html"><![CDATA[Merck KGaA]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Sanofi, GSK Make Novartis Look Scrooge-Like on Swine Flu Vaccine Donations]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10002783/sanofi-gsk-make-novartis-look-scrooge-like-on-swine-flu-vaccine-donations/]]></link>
		<description><![CDATA[The corporate image teams at Sanofi-Aventis and GlaxoSmithKline can pop the champagne for their victory over Novartis on the swine flu vaccine issue. Sanofi and GSK are giving away their vaccines free; Novartis has refused to do that. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sat, 20 Jun 2009 13:45:49 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/h1n1+flu.html"><![CDATA[H1N1 Flu]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[FDA Says Gardasil May Cause Fainting; The Stats Say It Doesn't]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10002712/fda-says-gardasil-may-cause-fainting-the-stats-say-it-doesnt/]]></link>
		<description><![CDATA[The FDA has demanded Merck add a new warning to its Gardasil HPV vaccine: That it may cause fainting. The news is already being hyped as yet more "proof" that the vaccine is a socialist plot to encourage American girls to have sex. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 15 Jun 2009 14:01:28 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Wyeth Q1 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-292997.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions Your first question comes from [Doug Subleman] - Sanford Bernstein [Doug Subleman] - Sanford Bernstein Can we get an update on when we might see the Prevnar 13 data in adults for the Phase three program, and is that likely to occur before the end...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Wed, 29 Apr 2009 09:23:20 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/sanford+c.+bernstein+%2526+co..html"><![CDATA[Sanford C. Bernstein & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
		<category domain="tickers">WYE</category>
	</item>
	<item>
		<title><![CDATA[Sanofi Gets Jennifer Lopez to Hawk Pentacell Pertussis Vaccine]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001800/sanofi-gets-jennifer-lopez-to-hawk-pentacell-pertussis-vaccine/]]></link>
		<description><![CDATA[Sanofi Pasteur, the vaccines unit of Sanofi-Aventis, has persuaded singer Jennifer Lopez to become its joint spokesperson with the March of Dimes' "the Sounds of Pertussis," campaign. (There's even a video, in which Lopez looks strangely like Law & Order's Mariska Hargitay.)    The effort is to persuade...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 23 Apr 2009 13:37:13 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cough.html"><![CDATA[Cough]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi.html"><![CDATA[Sanofi]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[U.S. Government to Stockpile Smallpox Antivirals]]></title>
		<link><![CDATA[http://industry.bnet.com/government/1000812/us-government-to-stockpile-smallpox-antivirals/]]></link>
		<description><![CDATA[This press release at MSNBC discusses the intent of SIGA Technologies to respond to a recent U.S. Department of Health and Human Services HHS RFP for treatment courses for people infected with smallpox.  This is the latest in a series of contracts related to preparations for outbreaks of diseases...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 13 Mar 2009 10:52:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/rfp.html"><![CDATA[RFP]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+health+and+human+services.html"><![CDATA[U.S. Department Of Health And Human Services]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+government.html"><![CDATA[U.S. Government]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/matthew+potter.html"><![CDATA[Matthew Potter]]></category>
		<category domain="http://resources.bnet.com/topic/matthew+potter.html"><![CDATA[Matthew Potter]]></category>
	</item>
	<item>
		<title><![CDATA[NEJM: Foreign Drug Trials Could Hurt U.S. Patients]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001071/nejm-foreign-drug-trials-could-hurt-us-patients/]]></link>
		<description><![CDATA[The increasing use of foreign drug trials may hurt U.S. patients because of genetic and environmental differences in overseas study subjects, a new study in the New England Journal of Medicine suggests. "Are trial results accurate and valid, and can they be extrapolated to other settings?" asks a team from...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 19 Feb 2009 07:56:45 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/u.s..html"><![CDATA[U.S.]]></category>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/india.html"><![CDATA[India]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://resources.bnet.com/topic/clinical+trial.html"><![CDATA[Clinical Trial]]></category>
		<category domain="http://resources.bnet.com/topic/trial.html"><![CDATA[Trial]]></category>
		<category domain="http://resources.bnet.com/topic/argentine+authority.html"><![CDATA[Argentine Authority]]></category>
		<category domain="http://resources.bnet.com/topic/gsk.html"><![CDATA[GSK]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
</channel>
</rss>
